THE DEAL, AT A GLANCE
From the announcementAureka
What it doesAureka Biotechnologies is an AI-native TechBio company building next-generation biological foundation models and closed-loop AI-native infrastructure to transform the…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Who is involvedBacked by Menlo Ventures’ Anthology Fund, with Thrive, OpenAI, Fred EhrsamFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗What happenedAureka raised Series B, announced 2026-08-11From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Why it mattersAureka’s $100M Series B is a sector-positioning signal for AI-native TechBio inside the Robotics-tagged funding pool, with the round sitting above the median but not at…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Aureka · Financing Record
Explore source-linked visual explanations for Aureka. Unsupported claims are withheld while source review continues.
Record 10010 · Recorded date: 2026-08-11
Explore company records →